DJIA 17,712.66 34.43 0.19%
NASDAQ 4,891.22 27.86 0.57%
S&P 500 2,061.02 4.87 0.24%
market minute promo

OXIGENE, INC. (NASDAQ: OXGN)

1.42 0.03 (2.16%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

OXGN $1.42 2.16%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $1.40
Previous Close $1.39
Daily Range $1.34 - $1.45
52-Week Range $1.34 - $3.92
Market Cap $29.4M
P/E Ratio -2.96
Dividend (Yield) $0.00 (0.0%)
Volume 376,711
Average Daily Volume 507,326
Current FY EPS -$0.73

Sector

Healthcare

Industry

Drug Makers

OXIGENE, INC. (OXGN) Description

A biotechnology company developing novel small-molecule therapeutics to treat cancer and eye diseases. Website: http://www.oxigene.com/

News & Commentary

Inhibitex Investors: Why Shares Popped 115%

Great results for INX-189 send shares skyward.

Stocks Hitting 52-Week Lows

Morning Market Losers

OXiGENE's (OXGN) CEO Dave Chaplin on Q4 2014 Results - Earnings Call Transcript

OXiGENE (OXGN) Q4 2014 Results - Earnings Call Webcast

Sabby Management Buys 3 Biotech Stocks

Biotech Stock Mailbag: Aethlon Medical, Oxigene, Sarepta

OXiGENE Announces Issuance Of European Patent for OXi4503 In Acute Myeloid Leukemia And Other Myeloi

OXiGENE Announces Issuance Of European Patent for OXi4503 In Acute Myeloid Leukemia And Other Myeloid Malignancies

Which Chemotherapy Should OXiGENE Test Their Zybrestat+Avastin Combo Against?

OXiGENE: Q3 Earnings And Avastin Approval, Bull Thesis Reiterated

Oxigene: Why I Think This Risky Biotech Is A Speculative Buy

See More OXGN News...

OXGN's Top Competitors

OXGN $1.42 (2.16%)
Current stock: OXGN
AMGN $162.59 (1.27%)
Current stock: AMGN
GILD $101.00 (-0.07%)
Current stock: GILD
BIIB $429.87 (0.22%)
Current stock: BIIB